Skip to content

RadNet RDNT Free cash flow

Free cash flow at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$112M+14.3%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$121.9M+23.3%
Danaher logo
DanaherDHR
$1.09B+2.9%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
-$15.8M-182%
Tenet Healthcare logo
Tenet HealthcareTHC
Universal Health Services logo
Universal Health ServicesUHS

Other financials

Income statement

See full
Revenue$575.6M+22.1%
Operating income-$23.9M+0.8%
Net income-$33.5M+11.8%
EPS (diluted)-$0.43+15.7%

Balance sheet

See full
Cash & equivalents$455.3M-36.5%
Total debt$1.9B+10.8%
Total equity$1.1B+20.3%
Total assets$3.9B+16.5%

Cash flow

See full
Operating cash flow$79.0M+90.4%
CapEx$69.9M+43.2%

Valuation

See full
Market cap$4.23B+17.8%
Enterprise value$5.7B+23.5%
P/S+0.1×

Profitability

See full
Gross margin13.4%
Operating margin2.9%-0.8pp
Net margin-0.7%-0.3pp
FCF margin5.1%+0.9pp

Returns & leverage

See full
Return on equity-1.4%-0.5pp
Debt / equity1.8×-0.2×
Current ratio1.2×-0.8×

Where this comes from

Calculated from RadNet’s reported figures.

The official record: RadNet’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about RadNet's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RadNet's free cash flow?
RadNet (RDNT) reported free cash flow of $9.04M in Q1 2026.
How has RadNet's free cash flow changed year-over-year?
RadNet's free cash flow increased by 223.0% year-over-year, from -$7.35M to $9.04M.
What is the long-term trend for RadNet's free cash flow?
Over 3 years (2021 to 2025), RadNet's free cash flow has grown at a 99.0% compound annual growth rate (CAGR), from $11.82M to $93.19M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.